Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy

E Muchtar, LA Blauwet, MA Gertz - Circulation research, 2017 - Am Heart Assoc
Restrictive cardiomyopathy (RCM) is characterized by nondilated left or right ventricle with
diastolic dysfunction. The restrictive cardiomyopathies are a heterogenous group of …

Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

P Chareonthaitawee, RS Beanlands, W Chen… - 2017 - Springer
Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …

Diagnostic accuracy of cardiac MRI versus FDG PET for cardiac sarcoidosis: a systematic review and meta-analysis

M Aitken, MV Chan, C Urzua Fresno, A Farrell, N Islam… - Radiology, 2022 - pubs.rsna.org
Background There is limited consensus regarding the relative diagnostic performance of
cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac sarcoidosis. Purpose To perform …

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association …

European Heart Journal-Cardiovascular Imaging, 2017 - academic.oup.com
This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review

NA Gilotra, JM Griffin, N Pavlovic, BA Houston… - Journal of cardiac …, 2022 - Elsevier
The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts
cardiac function through granulomatous infiltration of the heart, resulting in conduction …

[HTML][HTML] Cardiac sarcoidosis: diagnosis and management

E Markatis, A Afthinos, E Antonakis… - Reviews in …, 2020 - imrpress.com
Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

PET imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers

P Saric, KA Young, M Rodriguez-Porcel… - Pharmaceuticals, 2021 - mdpi.com
Sarcoidosis is a multi-system inflammatory disease characterized by the development of
inflammation and noncaseating granulomas that can involve nearly every organ system …

Management of cardiac sarcoidosis: a clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC …

R Sharma, V Kouranos, LT Cooper… - European heart …, 2024 - academic.oup.com
Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with
significant clinical complications such as high-degree atrioventricular block, ventricular …

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis

E Cheung, S Ahmad, M Aitken, R Chan… - European journal of …, 2021 - Springer
Purpose To evaluate the diagnostic and prognostic significance of combined cardiac 18F-
fluorodeoxyglucose (FDG) PET/MRI with T1/T2 mapping in the evaluation of suspected …